---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-121466"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:15:14.525369+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq deficiency notice on June 23, 2025 for failing $1.00 minimum bid price rule 5550(a)(2).
- Compliance deadline was December 22, 2025; on December 12, 2025 Nasdaq confirmed compliance.
- Common stock (KTTA) maintained closing bid at or above $1.00 for sufficient consecutive business days.
- Nasdaq notified company that the bid price deficiency matter is now closed.

## SEC filing metadata
- accession: 0001213900-25-121466
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025121466/0001213900-25-121466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025121466/ea0269602-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-121466
- JSON: https://secwatch.observer/filing/0001213900-25-121466.json
- Plain text: https://secwatch.observer/filing/0001213900-25-121466.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.